Theralase Technologies Inc - ESG Rating & Company Profile powered by AI
This webpage is a zero-cost Sustainability analysis for Theralase Technologies Inc. Other corporations in the scoring peer group for Theralase Technologies Inc are shown below. The assessment of Theralase Technologies Inc is prepared by All Street Sevva using proprietary NLP.
Theralase Technologies Inc in the Advanced Medical Equipment & Technology industry gained a UN SDG ESG Transparency Score of 3.6; made up of an environmental score of 0.0, social score of 8.0 and governance score of 2.7.
3.6
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Calmark Sweden AB | 8.0 | High |
1 | CHC Healthcare Group | 8.0 | High |
... | ... | ... | |
158 | Cambridge Cognition Holdings PLC | 3.7 | Medium |
158 | ABIOMED Inc | 3.7 | Medium |
160 | Theralase Technologies Inc | 3.6 | Medium |
160 | Neodynamics AB (publ) | 3.6 | Medium |
160 | Nano-X Imaging Ltd | 3.6 | Medium |
... | ... | ... | |
260 | Zhuhai Hokai Medical Instruments Co Ltd | 0.0 | Low |
260 | Zynex Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Theralase Technologies Inc have an accelerator or VC vehicle to help deliver innovation?
Does Theralase Technologies Inc disclose current and historical energy intensity?
Does Theralase Technologies Inc report the average age of the workforce?
Does Theralase Technologies Inc reference operational or capital allocation in relation to climate change?
Does Theralase Technologies Inc disclose its ethnicity pay gap?
Does Theralase Technologies Inc disclose cybersecurity risks?
Does Theralase Technologies Inc offer flexible work?
Does Theralase Technologies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Theralase Technologies Inc disclose the number of employees in R&D functions?
Does Theralase Technologies Inc conduct supply chain audits?
Does Theralase Technologies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Theralase Technologies Inc conduct 360 degree staff reviews?
Does Theralase Technologies Inc disclose the individual responsible for D&I?
Does Theralase Technologies Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Theralase Technologies Inc disclose current and / or historical scope 2 emissions?
Does Theralase Technologies Inc disclose water use targets?
Does Theralase Technologies Inc have careers partnerships with academic institutions?
Did Theralase Technologies Inc have a product recall in the last two years?
Does Theralase Technologies Inc disclose incidents of discrimination?
Does Theralase Technologies Inc allow for Work Councils/Collective Agreements to be formed?
Has Theralase Technologies Inc issued a profit warning in the past 24 months?
Does Theralase Technologies Inc disclose parental leave metrics?
Does Theralase Technologies Inc disclose climate scenario or pathway analysis?
Does Theralase Technologies Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Theralase Technologies Inc disclose the pay ratio of women to men?
Does Theralase Technologies Inc support suppliers with sustainability related research and development?
Does Theralase Technologies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Theralase Technologies Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Theralase Technologies Inc involved in embryonic stem cell research?
Does Theralase Technologies Inc disclose GHG and Air Emissions intensity?
Does Theralase Technologies Inc disclose its waste policy?
Does Theralase Technologies Inc report according to TCFD requirements?
Does Theralase Technologies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Theralase Technologies Inc disclose energy use targets?
Does Theralase Technologies Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Theralase Technologies Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Theralase Technologies Inc
These potential risks are based on the size, segment and geographies of the company.
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II for the treatment of Bacillus Calmette Guérin - Unresponsive Carcinoma In-Situ non-muscle invasive bladder cancer. Further, its product candidates include TLC-2000, a superpulsed and visible red laser technology accelerates healing by reducing pain and inflammation while staying below the Maximal Permissible Exposure limit for tissue, as well as related accessories. Additionally, it provides controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100. The company has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiology Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. It sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is based in Toronto, Canada.